awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q47813600-007C8F60-EB9F-4DCC-9C06-26C42F5D7570
Q47813600-007C8F60-EB9F-4DCC-9C06-26C42F5D7570
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47813600-007C8F60-EB9F-4DCC-9C06-26C42F5D7570
Network meta-analysis of second-line treatment in metastatic renal cell carcinoma: efficacy and safety.
P2860
Q47813600-007C8F60-EB9F-4DCC-9C06-26C42F5D7570
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47813600-007C8F60-EB9F-4DCC-9C06-26C42F5D7570
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
53dac6de7b750f6daf01255b97c0e90e5fd97641
P2860
Contemporary trends in high-dose interleukin-2 use for metastatic renal cell carcinoma in the United States.